CERUS CORP
CERS · NASDAQ
更新于 2026-10-15 06:44:56
- 今日最高
- $2.25
- 今日最低
- $2.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $2.23
- 昨日收盘价
- $2.24
- 成交量
- 289.02万
- 市值
- $4.51亿
- 本益比（P/E）
- --
- 每股收益（EPS）
- $-0.03
昨日价格区间
52周价格区间
公司概况
- 板块
- HEALTHCARE
- 行业
- Health Care
- 子行业
- MEDICAL DEVICES
- 总部
- 1220 CONCORD AVENUE, CONCORD, CA, UNITED STATES, 94520
- 国家
- US
- 上市日期
- 1997-01-31
- 财年截止
- December
- 流通股数
- 2亿
- CIK
- 0001020214
- 官方网址
- www.cerus.com
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
财务指标
营业收入
2026-06-30
$5744.1万
2026-03-31
$5366.1万
2025-12-31
$5775.1万
2025-09-30
$5269.8万
营业支出
2026-06-30
$3139万
2026-03-31
$2824.8万
2025-12-31
$3039万
2025-09-30
$2690.4万
净利润
2026-06-30
-$294万
2026-03-31
-$164万
2025-12-31
-$218.4万
2025-09-30
-$1.9万
净利润率
2026-06-30
-5.11%
2026-03-31
-3.05%
2025-12-31
-3.78%
2025-09-30
-0.03%
每股收益
2026-06-30
$-0.01
2026-03-31
$-0.01
2025-12-31
$-0.01
2025-09-30
$0.00
息税折旧摊销前利润
2026-06-30
-$71.2万
2026-03-31
$76.2万
2025-12-31
$29.2万
2025-09-30
$256.6万
有效税率
2026-06-30
-3.29%
2026-03-31
-5.84%
2025-12-31
-5.76%
2025-09-30
130.76%
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 营业收入 | $5744.1万 | $5366.1万 | $5775.1万 | $5269.8万 |
| 营业支出 | $3139万 | $2824.8万 | $3039万 | $2690.4万 |
| 净利润 | -$294万 | -$164万 | -$218.4万 | -$1.9万 |
| 净利润率 | -5.11% | -3.05% | -3.78% | -0.03% |
| 每股收益 | $-0.01 | $-0.01 | $-0.01 | $0.00 |
| 息税折旧摊销前利润 | -$71.2万 | $76.2万 | $29.2万 | $256.6万 |
| 有效税率 | -3.29% | -5.84% | -5.76% | 130.76% |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。